Microcystic adnexal carcinoma

Microcystic adnexal carcinoma
A microscopic view of microcystic adnexal carcinoma
SpecialtyDermatology/oncology

Microcystic adnexal carcinoma (MAC) is a rare sweat gland cancer,[1] which often appears as a yellow spot or bump in the skin. It usually occurs in the neck or head, although cases have been documented in other areas of the body. Most diagnosis occur past the age of 50. Although considered an invasive cancer, metastasis rarely occurs. If the tumor spreads, it can grow and invade fat, muscles, and other types of tissue.[2] Main treatments are wide local excision or Mohs micrographic surgery, which ensures that most, if not all, cancer cells are removed surgically.[3]

Symptoms and signs

Microcystic adnexal carcinoma -a, b) Individual at 26 years of age c) The individual at age 13, there was a freckle on his left cheek

MACs usually present as a smooth, flesh or yellow colored, slow-growing nodule or bump somewhere on the face or neck with typical development being 3–5 years. The most common location is the mouth (occurring in 74% of cases), however cases have been documented on the scalp, tongue, trunk, upper extremities, and genitals. Patients are more likely to be white, female, and middle aged or elderly, although cases have been documented in children.

Although usually presenting with no visual or physical symptoms, some patients do experience numbness, paresthesia, burning, or tingling. This may be due to the invasive nature of MACs, which can burrow deep into underlying tissues and nerves in the face. MAC is very difficult to recognize and differentiate from other conditions. Specialists may suggest a series of tests including a biopsy, an MRI, or a CT scan.[4] The average tumor size is less than 2 cm, however cases have been documented where tumor size exceeds 7.9 cm.[1] While death is rare among MAC patients, it can occasionally metastasize to local lymph nodes.[5] The 10 year overall survival rate is 86.4%, however this is exceedingly close to many 10 year survival rates of populations without MACs present.[6]

Causes

Little is known about the causes of MACs, although some evidence has shown that ultraviolet light, radiation, and genes may be causation factors. A genetic role might also be plausible, according to some studies. [7]In several cases, patients developed a MAC after immunosuppression.[1]

Diagnosis

The diagnosis of Microcystic adnexal carcinoma can be done via skin biopsy[8]

Treatment

Due to the invasive nature of MACs, most cases are treated with wide local excision in order to decrease the rate of reoccurrence. Increasingly however, Mohs micrographic surgery is being employed as it allows more specific margins to be removed, along with decreasing the size of postoperative scars and disfigurement. In rare cases, tumors can be deemed inoperable due to their size and location under vital structures of the face. Chemotherapy and radiation treatment have been used when metastasis has occurred or when an excision cannot be performed,[9] but results have been inconclusive about their effectiveness. In some cases, radiation therapy has been shown to increase tumor size. While in other cases, it implies that it will decrease the success of the tumor regrowing.[9] Long term follow-up is necessary, as some cases of local recurrence have been documented 30 years after the original diagnosis.[1]

See also

References

  1. 1 2 3 4 Hamed, Nouran S.; Khachemoune, Amor (2015-07-01). "Microcystic adnexal carcinoma: A focused review and updates". Journal of Dermatology & Dermatologic Surgery. 19 (2): 80–85. doi:10.1016/j.jdds.2015.03.001. ISSN 2352-2410.
  2. ↑ "Microcystic Adnexal Carcinoma". Archived from the original on 21 October 2020. Retrieved 4 December 2020.
  3. ↑ "Microcystic adnexal carcinoma | Genetic and Rare Diseases Information Center (GARD) – an NCATS Program". rarediseases.info.nih.gov. Archived from the original on 2019-02-03. Retrieved 2019-02-03.
  4. ↑ "Microcystic Adnexal Carcinoma". Archived from the original on 21 October 2020. Retrieved 4 December 2020.
  5. ↑ Kitajima, Yasuo; Kamiya, Hideki; Sugie, Shigeyuki; Ban, Masanori (2003). "Microcystic Adnexal Carcinoma with Lymph Node Metastasis". Dermatology. 207 (4): 395–397. doi:10.1159/000074122. ISSN 1018-8665. PMID 14657634.
  6. ↑ Yu, James B.; Blitzblau, Rachel C.; Patel, Sonya C.; Decker, Roy H.; Wilson, Lynn D. (August 2009). "Surveillance, Epidemiology, and End Results (SEER) Database Analysis of Microcystic Adnexal Carcinoma (Sclerosing Sweat Duct Carcinoma) of the Skin". American Journal of Clinical Oncology. 33 (2): 125–7. doi:10.1097/coc.0b013e31819791eb. ISSN 0277-3732. PMID 19675445.
  7. ↑ Lountzis, Nektarios. "Microcystic Adnexal Carcinoma". Medscape. Archived from the original on 24 November 2020. Retrieved 4 December 2020.
  8. ↑ Wetter, Robyn; Goldstein, Glenn D. (November 2008). "Microcystic adnexal carcinoma: a diagnostic and therapeutic challenge". Dermatologic Therapy. 21 (6): 452–458. doi:10.1111/j.1529-8019.2008.00246.x. ISSN 1529-8019. Archived from the original on 1 September 2021. Retrieved 31 August 2021.
  9. 1 2 "Microcystic adnexal carcinoma of the face treated with radiation therapy: a case report and review of the literature". Archived from the original on 4 November 2020. Retrieved 4 December 2020.


Template:Epidermal-growth-stub

This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.